December 13, 2024

DigiCo REIT (ASX:DGT), a new real estate investment trust focused on data centres, has made its debut on the ASX. This was Australia’s largest initial public offering (IPO) in six years, since Viva Energy’s (ASX:VEA) 2018 listing, and the largest real-estate-related listing in over a decade. The IPO targeted $2bn in capital, but was oversubscribed, […]

Dec seasonality, Rates, Wages, Bitcoin, MYEFO to confirm return to deficit Investment markets and key developments over the past week Global shares were mixed over the last week with a back up in bond yields and a bit of profit taking after a strong run up weighing on US and Eurozone shares leading to small

Dr Leearne Hinch – CEO – INOVIQ Limited (ASX:IIQ) is developing and commercialising a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.

Dougal Ferguson – CEO – TMK Energy Limited’s (ASX:TMK) flagship project, the Gurvantes XXXV Project, is a comprehensive Coal Seam Gas exploration initiative covering an expansive area of approximately 8,400 km2 in the South Gobi basin of Mongolia.

Dr David Stamler – CEO – Alterity Therapeutics Limited (ASX:ATH) is developing first-in-class therapies to treat neurodegenerative disease. The company’s lead drug candidate, ATH434, has demonstrated efficacy in several animal models of Parkinsonian disorders and is being evaluated in clinical trials.

Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.